Floatz logo

RAMIFENTANYL

Anesthesia, Intratracheal

VA Pittsburgh Healthcare SystemSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Anesthesia, Intratracheal cohort.

Asset / SponsorPhaseRating
PROPOFOL
VA Pittsburgh Healthcare System
Phase 4BB
MIVACURIUM ION
VA Pittsburgh Healthcare System
Phase 4BB
Sevoflurane
VA Pittsburgh Healthcare System
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
VA Pittsburgh Healthcare System
Phase 4BB

Same molecule, other indications

RAMIFENTANYL is also rated in:

morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, GeneralDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →